M. E. Duszynski

CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model

M. Karunasiri, Olimjon Toirov, Parvathi Ranganathan, 2024, Blood advances.

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

R. Garzon, P. Malik, Yandi Gao, 2022, Blood.